Amarin Corp ADR (NASDAQ:AMRN)’s traded shares stood at 1.26 million during the last session, with the company’s beta value hitting 1.80. At the close of trading, the stock’s price was $0.56, to imply an increase of 9.12% or $0.04 in intraday trading. The AMRN share’s 52-week high remains $1.37, putting it -144.64% down since that peak but still an impressive 23.21% since price per share fell to its 52-week low of $0.43. The company has a valuation of $232.16M, with an average of 1.76 million shares in intraday trading volume over the past 10 days and average of 1.50 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Amarin Corp ADR (AMRN), translating to a mean rating of 4.33. Of 2 analyst(s) looking at the stock, 1 analyst(s) give AMRN a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.03.
Amarin Corp ADR (NASDAQ:AMRN) trade information
After registering a 9.12% upside in the last session, Amarin Corp ADR (AMRN) has traded red over the past five days. The 5-day price performance for the stock is 2.64%, and 22.66% over 30 days. With these gigs, the year-to-date price performance is 16.39%. Short interest in Amarin Corp ADR (NASDAQ:AMRN) saw shorts transact 18.72 million shares and set a 9.53 days time to cover.
The extremes give us $1.5 and $3 for target low and target high price respectively. As such, AMRN has been trading -435.71% off suggested target high and -167.86% from its likely low.
Amarin Corp ADR (AMRN) estimates and forecasts
Looking at statistics comparing Amarin Corp ADR share performance against respective industry, we note that the company has underperformed competitors. Amarin Corp ADR (AMRN) shares are -28.55% down over the last 6 months, with its year-to-date growth rate lower than industry average at -600.00% against 16.70%. The rating firms project that company’s revenue will shrink -34.25% compared to the previous financial year.
Revenue forecast for the current quarter as set by 2 analysts is 31.69M. Meanwhile, for the current quarter, a total of 1 analyst(s) estimate revenue growth to 36.86M.Earnings reports from the last fiscal year show that sales brought in 74.71M and 56.52M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -57.58% before dropping -34.78% in the following quarter.
AMRN Dividends
Amarin Corp ADR has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Amarin Corp ADR (NASDAQ:AMRN)’s Major holders
Amarin Corp ADR insiders hold 1.60% of total outstanding shares, with institutional holders owning 17.05% of the shares at 17.33% float percentage. In total, 17.05% institutions holds shares in the company, led by SARISSA CAPITAL MANAGEMENT LP. As of 2024-06-30, the company held over 24.85 million shares (or 6.059% of shares), all amounting to roughly $17.1 million.
The next major institution holding the largest number of shares is KYNAM CAPITAL MANAGEMENT, LP with 12.16 million shares, or about 2.9638% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $8.36 million.
We also have SPDR Portfolio Developed World ex-US ETF and Delaware Group Equity Fds IV-Delaware Healthcare Fund as the top two Mutual Funds with the largest holdings of the Amarin Corp ADR (AMRN) shares. Going by data provided on Oct 31, 2024 , SPDR Portfolio Developed World ex-US ETF holds roughly 247.51 shares. This is just over 0.25% of the total shares, with a market valuation of $0.14 million. Data from the same date shows that the other fund manager holds a little less at 190.0, or 0.19% of the shares, all valued at about 0.11 million.
